首页> 外文期刊>In vivo. >Clinical and radiological outcome after endovascular abdominal aortic aneurysm repair: comparison of different grafts. preliminary single-center experience.
【24h】

Clinical and radiological outcome after endovascular abdominal aortic aneurysm repair: comparison of different grafts. preliminary single-center experience.

机译:血管内腹主动脉瘤修复后的临床和影像学结果:不同移植物的比较。初步的单中心经验。

获取原文
获取原文并翻译 | 示例
           

摘要

Endovascular repair (EVAR) represents a useful and validated alternative to conventional surgery in selected patients with abdominal aortic aneurysm (AAA) because it is associated with a significantly lower long-term AAA-related mortality. Data regarding a series of 91 patients (88 men, 3 women, median age 71 years, range 65-82 years) is reported. The patients were divided into three groups, according to the type of implanted stent (Endurant, Excluder and Talent). High American Society of Anesthesiologists Physical Status Classification System (ASA) was important in increasing the likelihood of an early complication (p=0.0007), while it did not have any effect on later adverse events, which were more closely related to the size of the aneurysm (p=0.006). As expected, the aneurysm diameter influenced the endoleak incidence (p=0.011), aneurysmal sac expansion (p=0.029), re-intervention risk (p=0.031) and the success of treatment (p=0.006). A significantly lower tendency for the development of endoleak (p=0.035) and other late complications (p=0.048) was observed in patients with Endurant device. This group seems to be more likely destined to achieve therapeutic success, but the difference was not significant. A borderline significance (p=0.071) with regard to early complications was also recorded. However, the use of this type of device did not affect survival, which was exclusively related to ASA (p=0.040). No other statistically significant differences were found between groups. Since open surgery for elective suprarenal AAA repair is still associated with considerable mortality, EVAR may offer several advantages over open repair surgery, including a less invasive operative procedure, and shortened intensive care unit and hospital stay. The technological improvements of the prosthesis for EVAR will likely reduce complications related to this technique in the near future.
机译:在选定的腹主动脉瘤(AAA)患者中,血管内修复(EVAR)代表了常规手术的一种有用且经过验证的替代方法,因为它与长期AAA相关的长期死亡率显着降低有关。报告了一系列91例患者的数据(男性88例,女性3例,中位年龄71岁,范围65-82岁)。根据植入支架的类型将患者分为三组(Endurant,Excluder和Talent)。高等麻醉医师学会身体状况分类系统(ASA)对于增加早期并发症的可能性很重要(p = 0.0007),而对以后的不良事件没有任何影响,后者与血栓的大小更密切相关动脉瘤(p = 0.006)。如预期的那样,动脉瘤直径影响内漏发生率(p = 0.011),动脉瘤囊扩张(p = 0.029),再次介入风险(p = 0.031)和治疗成功(p = 0.006)。在使用Endurant装置的患者中,观察到内漏发生的趋势(p = 0.035)和其他晚期并发症(p = 0.048)的趋势明显降低。该组似乎更有可能注定要获得治疗成功,但差异并不显着。还记录了早期并发症的临界意义(p = 0.071)。但是,使用这种类型的设备不会影响生存,这仅与ASA有关(p = 0.040)。两组之间没有发现其他统计学上的显着差异。由于选择性肾上腺AAA修复的开放手术仍具有较高的死亡率,因此EVAR可能比开放修复手术具有多个优势,包括侵入性较小的手术程序,缩短了重症监护病房和住院时间。 EVAR假体的技术改进可能会在不久的将来减少与此技术相关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号